The Board of Directors of Probi AB (publ) has appointed Anita Johansen as new Chief Executive Officer of Probi effective April 1, 2023. Anita Johansen has been employed with Probi since April 2022 as the Vice President of R&D and in the role as interim CEO since December 2022. Anita has more than 20 years of leadership experience from global consumer healthcare companies and an extensive experience with product development of nutritional and probiotic products.

Prior to joining Probi she held senior leadership positions in Pfizer Consumer Healthcare, Novozymes OneHealth and USP Zdrowie. Anita holds a master's degree in pharmacy and a PhD in pharmaceutical technology, both from the Danish University of Pharmaceutical Sciences (now University of Copenhagen) in Denmark.